The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Methylphenidate in the Treatment of Children and Adolescents With Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder
Abstract
Objective To examine the short-term efficacy of methylphenidate in the treatment of youths with bipolar disorder (BD) and comorbid attention deficit/hyperactivity disorder (ADHD). Method A 4-week double-blind, placebo-controlled trial in youths ages 5 to 17 years was conducted. Subjects met DSM-IV criteria for bipolar disorder and ADHD, were currently receiving a stable dose of at least one thymoleptic, and while euthymic continued to have clinically significant symptoms of ADHD. Patients received 1 week each of placebo, methylphenidate 5 mg twice daily, methylphenidate 10 mg twice daily, and methylphenidate 15 mg twice daily using a crossover design. Subjects were randomly assigned to receive one of six possible dosing orders. At study's end, and before the blind being broken, a "best dose week" for each subject was determined. The primary outcome measure was the total score on the parent-completed ADHD Rating Scale-IV. Results Sixteen patients, with a mean age of 10.43 (SD 3.14) years completed the trial. Lower scores during best dose treatment compared to the week of placebo treatment were found on the ADHD Rating Scale-IV (p Conclusions Euthymic youths with bipolar disorder and ADHD may benefit from short-term concomitant treatment with methylphenidate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjunctive mixed amphetamine salts (level 3)611 and methylphenidate (level 3)612 have both been shown to be effective in addressing attention symptoms and have been well tolerated overall within the RCTs completed to date,”
In the citing paper
“Mixed amphetamine salts (level 3),611 methylphenidate (level 3),612 atomoxetine (level 4),615 bupropion (level 4),766 or lisdexamfetamine (level 4)767 add‐ons to mood‐stabilizing treatments have been reported to be efficacious in improving ADHD symptoms.”
Citations
Cites
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Norussis, H. (1993) · Medical Entomology and Zoology · Cited by 2,704
Meta-analysis of experiments with matched groups or repeated measures designs
Dunlap, W. P., Cortina, J. M., Vaslow, J. B., & Burke, M. J. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.2.170 · Cited by 1,693
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Attention-Deficit Hyperactivity Disorder and Juvenile Mania: An Overlooked Comorbidity?
BIEDERMAN, J., FARAONE, S., MICK, E., WOZNIAK, J., CHEN, L., OUELLETTE, C., MARRS, A., MOORE, P., GARCIA, J., MENNIN, D., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199608000-00010 · Cited by 389
Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder
Findling, R. L., Gracious, B. L., McNamara, N. K., Youngstrom, E. A., Demeter, C. A., Branicky, L. A., & Calabrese, J. R. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030405.x · Cited by 341
Self-citationGeller, B., Zimerman, B., Williams, M., DelBello, M. P., Bolhofner, K., Craney, J. L., Frazier, J., Beringer, L., & Nickelsburg, M. J. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460252943533 · Cited by 322
Scheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.58 · Cited by 260
Findling, R. L., Mcnamara, N. K., Youngstrom, E. A., Stansbrey, R., Gracious, B. L., Reed, M. D., & Calabrese, J. R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155981.83865.ea · Cited by 252
Self-citation
Cited by
Items 101–120 of 120
O'Connor, H., Biederman, J., DiSalvo, M., Joshi, G., Faraone, S. V., & Wozniak, J. R. (2024) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2402031
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder Across the Life Span
Wilens, T. E., Prince, J. B., Stone, M., Biederman, J., Uchida, M., & Surman, C. B. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11972-9.00007-7
Repurposed Drugs of Abuse (Stimulants, Ketamine, and Psychedelics): Focus on Risks
Souza‐Marques, B., Caliman‐Fontes, A. T., Leal, G. C.-G., Bandeira, I. D., Mello, R. P., Alves-Pereira, R., & Quarantini, L. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_28
Rynn, M. A., Yanes-Lukin, P. K., Braun, D. A., & Goldberg, P. H. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg04
Chapter 5. Major Depressive Disorder
Birmaher, B. B. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg05
Amin, J., & Stout, G. A. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg10
Chapter 3. Disruptive Behavior Disorders and Aggression
Zaraa, S. G., Cunningham, N. R., Pappadopulos, E. A., & Jensen, P. S. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg03 · Cited by 1
Chapter 1. Developmental Aspects of Pediatric Psychopharmacology
Vitiello, B. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg01 · Cited by 2
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.fm02
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.fm01
Chapter 2. Attention-Deficit/Hyperactivity Disorder
Falkowitz, S. B., Akbar, N., & Greenhill, L. L. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg02
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.fm04
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.index
Thomas, T., Levy, J., & Findling, R. L. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg06
Self-citation(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.fm03
Chapter 7. Autism Spectrum Disorder
Palumbo, M. L., Keary, C. J., & McDougle, C. J. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg07 · Cited by 2
Scahill, L. D., Lytle, S., & Pope, S. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg08
Chapter 9. Early-Onset Schizophrenia and Psychotic Illnesses
Craddock, K. E. S., David, C. N., Driver, D. I., Gogtay, N., & RAPOPORT, J. L. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266.lg09
Diagnostic Conversion from Attention-Deficit/Hyperactivity Disorder to Bipolar Disorder
Bergmann, C. G., & Meller, M. R. (2025) · Springer eBooks · doi:10.1007/978-3-032-01297-5_6
Child and Adolescent Bipolar Disorder
Lee, M., & Shim, S. H. (2026) · Springer eBooks · doi:10.1007/978-981-92-1323-8_8
Metadata
- Authors
- FINDLING, R. L., SHORT, E. J., McNAMARA, N. K., DEMETER, C. A., STANSBREY, R. J., GRACIOUS, B. L., WHIPKEY, R., MANOS, M. J., & CALABRESE, J. R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- FINDLING, ROBERT L.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 46
- Issue
- 11
- Pages
- 1445-1453
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2069069376
- Cited by
- 120
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 21 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 11
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- methylphenidate, bipolar disorder, attention deficit hyperactivity disorder, comorbidities, children and adolescents, ADHD Rating Scale-IV, stimulant medication, treatment efficacy, tolerability
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Child, Child, Preschool, Double-Blind Method, Female, Humans, Male, Methylphenidate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.